United States · Bill · HR
H.R. 3008 (118th)
Drug Shortage Prevention Act of 2023
Introduced
28 April 2023
Last action
5 May 2023 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Jacobs, Sara [D-CA-51], Colin Allred, Rep. Clarke, Yvette D. [D-NY-9], Rep. Doggett, Lloyd [D-TX-37], Rep. García, Jesús G. "Chuy" [D-IL-4], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Huffman, Jared [D-CA-2], Rep. Khanna, Ro [D-CA-17], Rep. Larson, John B. [D-CT-1], Rep. Lee, Barbara [D-CA-12], Rep. McGovern, James P. [D-MA-2], Rep. Ocasio-Cortez, Alexandria [D-NY-14], Rep. Pressley, Ayanna [D-MA-7], Rep. Veasey, Marc A. [D-TX-33], Rep. Velázquez, Nydia M. [D-NY-7], Rep. Watson Coleman, Bonnie [D-NJ-12], Rep. Carter, Troy A. [D-LA-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Cohen, Steve [D-TN-9], Rep. Cleaver, Emanuel [D-MO-5], Rep. Smith, Adam [D-WA-9], Sen. Blunt Rochester, Lisa [D-DE], Rep. Crockett, Jasmine [D-TX-30], Rep. Kuster, Ann M. [D-NH-2], Rep. Tokuda, Jill N. [D-HI-2], Yadira Caraveo, Sen. Schiff, Adam B. [D-CA], Rep. Jackson Lee, Sheila [D-TX-18], Sen. Kim, Andy [D-NJ], Rep. Mills, Cory [R-FL-7], Rep. Castor, Kathy [D-FL-14], Rep. Craig, Angie [D-MN-2], Sen. Slotkin, Elissa [D-MI], Rep. Bice, Stephanie I. [R-OK-5], Rep. Sarbanes, John P. [D-MD-3], Rep. Dean, Madeleine [D-PA-4], Rep. Ryan, Patrick [D-NY-18], Rep. Deluzio, Christopher R. [D-PA-17], Rep. Davids, Sharice [D-KS-3], Rep. Fletcher, Lizzie [D-TX-7], Rep. Cárdenas, Tony [D-CA-29], Rep. Peters, Scott H. [D-CA-50], Rep. Hoyle, Val T. [D-OR-4], Rep. Frost, Maxwell [D-FL-10], Rep. Leger Fernandez, Teresa [D-NM-3], Rep. Lynch, Stephen F. [D-MA-8], Rep. Quigley, Mike [D-IL-5], Rep. Pappas, Chris [D-NH-1]
Subjects
Healthcare
Source updated
27 May 2025
Summary
Drug Shortage Prevention Act of 2023 This bill requires drug manufacturers to notify the Food and Drug Administration (FDA) if there is an increased demand for certain critical essential medicines that may result in a shortage. Currently, drug manufacturers are required to notify the FDA in the event of a discontinuation or interruption in the supply of prescription drugs that are life-supporting, life-sustaining, or used for a debilitating disease or condition, including those used in medical emergencies, surgeries, or public health emergencies. The bill requires drug manufacturers to also notify the FDA if there is an increased demand for such drugs that lasts for at least six weeks and that may result in a shortage. Manufacturers must initially notify the FDA of the increased demand within 48 hours after this six-week period and must submit an additional notice within 30 days of the initial notification. The notice must include the reasons for the increased demand, the expected duration, and any other information the FDA requires. The bill's requirements apply to both prescription and nonprescription drugs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 April 2023
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
28 April 2023
Introduced
Introduced in House
Source: IntroReferral
28 April 2023
Introduced
Introduced in House
Source: IntroReferral
5 May 2023
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 28 April 2023 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 28 April 2023
Introduced in House (PDF)
Introduced in House · EN · 28 April 2023
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 28 April 2023
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Jacobs, Sara [D-CA-51] · D · Sponsor
- Colin Allred · D · Sponsor
- Rep. Clarke, Yvette D. [D-NY-9] · D · Sponsor
- Rep. Doggett, Lloyd [D-TX-37] · D · Sponsor
- Rep. García, Jesús G. "Chuy" [D-IL-4] · D · Sponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Sponsor
- Rep. Huffman, Jared [D-CA-2] · D · Sponsor
- Rep. Khanna, Ro [D-CA-17] · D · Sponsor
- Rep. Larson, John B. [D-CT-1] · D · Sponsor
- Rep. Lee, Barbara [D-CA-12] · D · Sponsor
- Rep. McGovern, James P. [D-MA-2] · D · Sponsor
- Rep. Ocasio-Cortez, Alexandria [D-NY-14] · D · Sponsor
- Rep. Pressley, Ayanna [D-MA-7] · D · Sponsor
- Rep. Veasey, Marc A. [D-TX-33] · D · Sponsor
- Rep. Velázquez, Nydia M. [D-NY-7] · D · Sponsor
- Rep. Watson Coleman, Bonnie [D-NJ-12] · D · Sponsor
- Rep. Carter, Troy A. [D-LA-2] · D · Sponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Sponsor
- Rep. Cohen, Steve [D-TN-9] · D · Sponsor
- Rep. Cleaver, Emanuel [D-MO-5] · D · Sponsor
- Rep. Smith, Adam [D-WA-9] · D · Sponsor
- Sen. Blunt Rochester, Lisa [D-DE] · D · Sponsor
- Rep. Crockett, Jasmine [D-TX-30] · D · Sponsor
- Rep. Kuster, Ann M. [D-NH-2] · D · Sponsor
- Rep. Tokuda, Jill N. [D-HI-2] · D · Sponsor
- Yadira Caraveo · D · Sponsor
- Sen. Schiff, Adam B. [D-CA] · D · Sponsor
- Rep. Jackson Lee, Sheila [D-TX-18] · D · Sponsor
- Sen. Kim, Andy [D-NJ] · D · Sponsor
- Rep. Mills, Cory [R-FL-7] · R · Sponsor
- Rep. Castor, Kathy [D-FL-14] · D · Cosponsor
- Rep. Craig, Angie [D-MN-2] · D · Cosponsor
- Sen. Slotkin, Elissa [D-MI] · D · Cosponsor
- Rep. Bice, Stephanie I. [R-OK-5] · R · Cosponsor
- Rep. Sarbanes, John P. [D-MD-3] · D · Cosponsor
- Rep. Dean, Madeleine [D-PA-4] · D · Cosponsor
- Rep. Ryan, Patrick [D-NY-18] · D · Cosponsor
- Rep. Deluzio, Christopher R. [D-PA-17] · D · Cosponsor
- Rep. Davids, Sharice [D-KS-3] · D · Cosponsor
- Rep. Fletcher, Lizzie [D-TX-7] · D · Cosponsor
- Rep. Cárdenas, Tony [D-CA-29] · D · Cosponsor
- Rep. Peters, Scott H. [D-CA-50] · D · Cosponsor
- Rep. Hoyle, Val T. [D-OR-4] · D · Cosponsor
- Rep. Frost, Maxwell [D-FL-10] · D · Cosponsor
- Rep. Leger Fernandez, Teresa [D-NM-3] · D · Cosponsor
- Rep. Lynch, Stephen F. [D-MA-8] · D · Cosponsor
- Rep. Quigley, Mike [D-IL-5] · D · Cosponsor
- Rep. Pappas, Chris [D-NH-1] · D · Cosponsor
Showing 48 of 51 sponsors and actors.
Related records
- related to ← Protecting PAHPA Act of 2023
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/3008
- Open data entity: https://api.congress.gov/v3/bill/118/hr/3008
- us · 118-hr-3008 · source updated 27 May 2025